Breathing machine may ease lung risk for kids with sickle cell

NCT ID NCT01501643

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a non-invasive breathing machine (ventilation) could prevent acute chest syndrome, a serious lung complication, in children with sickle cell disease who were hospitalized for severe pain. The standard prevention is spirometry, which requires active deep breathing, but pain and sleep can make that hard. The trial planned to compare the two approaches in children aged 6–20, but it was stopped early after enrolling only 6 participants, so no firm conclusions can be drawn.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
non-invasive positive pressure ventilation (device)
What this could lead to
If it worked, this approach could offer a more comfortable way to prevent a serious lung complication in children with sickle cell disease during painful crises.
What could go wrong
The trial was terminated early with only 6 participants, so we have very little data. It is unclear if the device is better than standard care, and results may not apply broadly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SICKLE CELL-HEMOGLOBIN SS DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hôpital Necker - Enfants Malades Hospital

    Paris, 75015, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.